Results 91 to 100 of about 14,990 (249)

Allergic bronchopulmonary aspergillosis mimicking miliary tuberculosis

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2018
Tuberculosis (TB) continues to be a major global health problem, especially in developing countries such as Indonesia. TB makes the individual more susceptible to other diseases caused by other microorganisms.
Gurmeet Singh   +2 more
doaj   +1 more source

A Case Report of Chlamydia Psittaci Pneumonia and Pulmonary Aspergillosis Diagnosed by Nanopore Sequencing

open access: yesiLABMED, Volume 3, Issue 3, Page 258-262, September 2025.
ABSTRACT This paper reports a case of Chlamydia psittaci pneumonia and pulmonary aspergillosis with concurrent liver injury. The patient was admitted to the hospital with coughing, expectoration, and fever for 5 days. Laboratory tests upon admission revealed abnormalities in liver function.
Chang Song   +5 more
wiley   +1 more source

Advances in bronchiectasis:endotyping, genetics, microbiome, and disease heterogeneity [PDF]

open access: yes, 2018
Bronchiectasis is characterised by pathological dilation of the airways. More specifically, the radiographic demonstration of airway enlargement is the common feature of a heterogeneous set of conditions and clinical presentations.
Chalmers, James D.   +2 more
core   +2 more sources

Treatment of Infections Due to Aspergillus terreus Species Complex

open access: yesJournal of Fungi, 2018
The Aspergillus terreus species complex is found in a wide variety of habitats, and the spectrum of diseases caused covers allergic bronchopulmonary aspergillosis, Aspergillus bronchitis and/or tracheobronchitis, and invasive and disseminated ...
Cornelia Lass-Flörl
doaj   +1 more source

A Fungal Glycosphingolipid Directly Activates Natural Killer T Cells and Rapidly Induces Airways Disease [PDF]

open access: yes, 2014
Aspergillus fumigatusis a saprophytic fungus that is ubiquitous in the environment and commonly associated with allergic sensitization and severe asthma in humans. Although A.
Albacker, Lee A.   +8 more
core   +1 more source

Sputum Microbiota Compositions Correlate With Metabolome and Clinical Outcomes of COPD‐Bronchiectasis Association: A Prospective Cohort Study

open access: yesExploration, Volume 5, Issue 4, August 2025.
This study aimed to determine how microbiota compositions (via 16S rRNA sequencing) correlate with clinical outcome and metabolome (via liquid chromatography/mass spectrometry) of CBA. Sputum microbiome and metabolome profiles of CBA were well separated from COPD but not bronchiectasis, partly driven by the higher abundance of Proteobacteria in CBA ...
Zhen‐feng He   +16 more
wiley   +1 more source

Aspergilloma as a Skull Base Tumor: A Case Report [PDF]

open access: yesCaspian Journal of Neurological Sciences
Background: Aspergillosis is a fungus-related health problem that may include allergic reactions like allergic bronchopulmonary aspergillosis, which presents as upper and lower airway disease or chronic and invasive forms of fungal infection.
Sevil Nasirmohtaram   +4 more
doaj  

Guillain–Barre Syndrome in Patients With Cystic Fibrosis: A Case Series

open access: yesRespirology Case Reports, Volume 13, Issue 8, August 2025.
We present four cases of Guillain–Barre Syndrome in adult patients with cystic fibrosis. We highlight the particularly detrimental impact that can occur in a population of patients with chronic underlying suppurative airway disease, impaired lung function and metabolic dysregulation.
James Nolan   +4 more
wiley   +1 more source

Interaction of the pathogenic mold Aspergillus fumigatus with lung epithelial cells [PDF]

open access: yes, 2012
Aspergillus fumigatus is an opportunistic environmental mold that can cause severe allergic responses in atopic individuals and poses a life-threatening risk for severely immunocompromised patients.
Nir Osherov
core   +2 more sources

CT‐P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double‐Blind, Randomized, Active‐Controlled, Phase 3 Study

open access: yesAllergy, Volume 80, Issue 8, Page 2167-2177, August 2025.
This study investigated the therapeutic equivalence of CT‐P39 (an omalizumab biosimilar) and EU‐approved reference omalizumab (ref‐OMA) in patients with chronic spontaneous urticaria. Therapeutic equivalence between CT‐P39 and ref‑OMA (300 mg) was demonstrated by the primary endpoint – confidence intervals of the treatment difference in mean change ...
Sarbjit S. Saini   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy